ROSINACK MATTHEW W. enters IOVANCE BIOTHERAPEUTICS, INC. with 89.13K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/10/2025ACC: 0001104659-25-066983
Officer· SVP, Finance (Int. PFO & PAO)
Since Jun 2025
89.13K
Baseline shares
100% direct
89.13K
Direct ownership
1 position
184.07K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned89.13K
Total
89.13K direct89.13K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 89.13K | Direct |
| Total | 89.13K | 89.13K direct |
Derivative Holdings4
Stock Options (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
75K
Shares owned
N/A
Exercise price
25.30
Expiration
—
Exercise window
—
Restricted Stock Units
DirectUnderlying security
Common Stock
Underlying shares
59.06K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Restricted Stock Units
DirectUnderlying security
Common Stock
Underlying shares
38.29K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Restricted Stock Units
DirectUnderlying security
Common Stock
Underlying shares
11.72K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
184.07K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock | 25.30 | — | — | 75K | N/A |
| Restricted Stock Units Direct | Common Stock | — | — | 59.06K | N/A | |
| Restricted Stock Units Direct | Common Stock | — | — | 38.29K | N/A | |
| Restricted Stock Units Direct | Common Stock | — | — | 11.72K | N/A | |
| Total | 184.07K | 0.00 | ||||